|
BR6915369D0
(pt)
*
|
1969-02-27 |
1973-03-13 |
Bayer Ag |
Emprego de inibidores biologicos de proteases para conservacao de orgaos tecidos e alimentos
|
|
US3691016A
(en)
*
|
1970-04-17 |
1972-09-12 |
Monsanto Co |
Process for the preparation of insoluble enzymes
|
|
US3940475A
(en)
|
1970-06-11 |
1976-02-24 |
Biological Developments, Inc. |
Radioimmune method of assaying quantitatively for a hapten
|
|
CA1023287A
(en)
*
|
1972-12-08 |
1977-12-27 |
Boehringer Mannheim G.M.B.H. |
Process for the preparation of carrier-bound proteins
|
|
US4179337A
(en)
*
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
DE2619246A1
(de)
*
|
1976-04-30 |
1977-11-10 |
Bayer Ag |
Desamino-derivate des kallikrein- trypsin-inhibitors, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
|
|
US4195128A
(en)
*
|
1976-05-03 |
1980-03-25 |
Bayer Aktiengesellschaft |
Polymeric carrier bound ligands
|
|
DE2654124A1
(de)
*
|
1976-11-29 |
1978-06-01 |
Bayer Ag |
Derivate des trypsin-kallikrein-inhibitors aus rinderorganen (bpti) mit proteasenhemmwirkung und antiphlogistischer wirkung, ihre herstellung und ihre verwendung als arzneimittel
|
|
US4330440A
(en)
*
|
1977-02-08 |
1982-05-18 |
Development Finance Corporation Of New Zealand |
Activated matrix and method of activation
|
|
CA1093991A
(en)
*
|
1977-02-17 |
1981-01-20 |
Hideo Hirohara |
Enzyme immobilization with pullulan gel
|
|
US4229537A
(en)
*
|
1978-02-09 |
1980-10-21 |
New York University |
Preparation of trichloro-s-triazine activated supports for coupling ligands
|
|
US4289747A
(en)
|
1978-12-26 |
1981-09-15 |
E-Y Laboratories, Inc. |
Immunological determination using lectin
|
|
AT359653B
(de)
*
|
1979-02-15 |
1980-11-25 |
Immuno Ag |
Verfahren zur herstellung eines gewebekleb- stoffes
|
|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4634665A
(en)
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4376110A
(en)
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
AU560584B2
(en)
|
1983-07-28 |
1987-04-09 |
Bayer Aktiengesellschaft |
Homologues of aprotinin
|
|
US4657893A
(en)
*
|
1984-05-09 |
1987-04-14 |
Syntex (U.S.A.) Inc. |
4H-3,1-benzoxazin-4-ones and related compounds and use as enzyme inhibitors
|
|
US4845242A
(en)
*
|
1987-04-28 |
1989-07-04 |
Georgia Tech Research Corporation |
Isocoumarins with basic substituents as serine proteases inhibitors, anticoagulants and anti-inflammatory agents
|
|
US4609725A
(en)
*
|
1984-10-09 |
1986-09-02 |
Merck & Co., Inc. |
Cardiac atrial peptides
|
|
US5374548A
(en)
|
1986-05-02 |
1994-12-20 |
Genentech, Inc. |
Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
|
|
MX9203291A
(es)
|
1985-06-26 |
1992-08-01 |
Liposome Co Inc |
Metodo para acoplamiento de liposomas.
|
|
CA1312564C
(en)
|
1985-07-12 |
1993-01-12 |
Robert W. Colman |
Monoclonal antibodies to human plasma prekallikrein and methods of preparing and using same
|
|
US5444156A
(en)
*
|
1985-07-12 |
1995-08-22 |
Temple University-Of The Commonwealth System Of Higher Education |
Monoclonal antibodies to human plasma prekallikrein
|
|
JPH0623113B2
(ja)
|
1986-01-31 |
1994-03-30 |
浩 前田 |
癌性胸・腹水貯留抑制剤
|
|
US4868103A
(en)
|
1986-02-19 |
1989-09-19 |
Enzo Biochem, Inc. |
Analyte detection by means of energy transfer
|
|
WO1987005396A1
(en)
*
|
1986-03-03 |
1987-09-11 |
Brigham And Women's Hospital |
A method for evaluating nephrotoxicity
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
EP0255011A3
(en)
|
1986-07-29 |
1988-11-23 |
Miles Inc. |
Human inter-alpha-trypsin inhibitor gene
|
|
US4881175A
(en)
|
1986-09-02 |
1989-11-14 |
Genex Corporation |
Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
US4946778A
(en)
*
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
DE3752253T2
(de)
|
1986-11-17 |
1999-05-27 |
Scios Inc |
Rekombiniertes Alzheimer Amyloid-Protein.
|
|
EP0285123A3
(en)
|
1987-04-03 |
1989-02-01 |
Stabra AG |
A method for complete mutagenesis of nucleic acids
|
|
IL87172A
(en)
|
1987-07-23 |
1994-12-29 |
Univ Washington |
Method of isolating highly purified tissue factor inhibitor
|
|
US4966852A
(en)
*
|
1987-07-23 |
1990-10-30 |
Monsanto Company |
DNA clone of human tissue factor inhibitor
|
|
US5106833A
(en)
*
|
1987-07-23 |
1992-04-21 |
Washington University |
Coagulation inhibitors
|
|
GB2208511A
(en)
|
1987-08-07 |
1989-04-05 |
Bayer Ag |
Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
|
|
DK225488D0
(da)
*
|
1988-04-26 |
1988-04-26 |
Novo Industri As |
Polypeptid
|
|
ATE81724T1
(de)
|
1987-11-09 |
1992-11-15 |
Becton Dickinson Co |
Verfahren zur analyse haematopoietischer zellen in einer probe.
|
|
IL87171A
(en)
|
1987-11-23 |
1995-08-31 |
Monsanto Co |
cDNA of human tissue factor inhibitor
|
|
US5045452A
(en)
*
|
1988-09-02 |
1991-09-03 |
Brigham And Women's Hospital |
Method for evaluating nephrotoxicity
|
|
US7078383B2
(en)
|
1988-09-02 |
2006-07-18 |
Dyax Corp. |
ITI-D1 Kunitz domain mutants as HNE inhibitors
|
|
US5663143A
(en)
*
|
1988-09-02 |
1997-09-02 |
Dyax Corp. |
Engineered human-derived kunitz domains that inhibit human neutrophil elastase
|
|
EP1997891A1
(en)
|
1988-09-02 |
2008-12-03 |
Dyax Corporation |
Generation and selection of recombinant varied binding proteins
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5372933A
(en)
*
|
1988-10-03 |
1994-12-13 |
The Scripps Research Institute |
Polypeptides that mimic receptor-induced binding sites, and methods of using same
|
|
US5750373A
(en)
|
1990-12-03 |
1998-05-12 |
Genentech, Inc. |
Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
EP0401508B1
(de)
*
|
1989-05-13 |
1994-11-23 |
Bayer Ag |
Proteinaseninhibitoren, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
|
|
US5030002A
(en)
|
1989-08-11 |
1991-07-09 |
Becton, Dickinson And Company |
Method and apparatus for sorting particles with a moving catcher tube
|
|
DK408089D0
(da)
*
|
1989-08-18 |
1989-08-18 |
Novo Nordisk As |
Proteiner
|
|
US5378614A
(en)
*
|
1989-08-18 |
1995-01-03 |
Novo Nordisk A/S |
Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast
|
|
US5278285A
(en)
*
|
1990-02-01 |
1994-01-11 |
Bayer Aktiengesellschaft |
Variant of Kunitz-type inhibitor derived from the α3-chain of human type VI collagen produced by recombinant DNA technology
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
EP0585287B1
(en)
|
1990-07-10 |
1999-10-13 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
IE76732B1
(en)
|
1990-08-07 |
1997-11-05 |
Becton Dickinson Co |
One step test for absolute counts
|
|
US5278144A
(en)
*
|
1990-09-04 |
1994-01-11 |
Cor Therapeutics, Inc. |
Antithrombosis agents
|
|
US5583107A
(en)
*
|
1990-09-04 |
1996-12-10 |
Cor Therapeutics, Inc. |
Agents affecting thrombosis and hemostasis
|
|
IL99585A0
(en)
|
1990-10-01 |
1992-08-18 |
Novo Nordisk As |
Aprotinin analogues,their production and pharmaceutical compositions containing them
|
|
US5409895A
(en)
*
|
1990-11-13 |
1995-04-25 |
Mochida Pharmaceutical Co., Ltd. |
Protease inhibitory polypeptides derived from urinary trypsin inhibitor and compositions thereof
|
|
US5304122A
(en)
|
1991-02-14 |
1994-04-19 |
Medtronic, Inc. |
Method for providing a restenosis model in porcine coronary arteries
|
|
US5370901A
(en)
|
1991-02-15 |
1994-12-06 |
Bracco International B.V. |
Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
|
|
DK1820858T3
(da)
|
1991-03-01 |
2009-11-02 |
Dyax Corp |
Kimært protein omfatende mikroprotein med to eller flere disulfidbindinger og udförelsesformer deraf
|
|
US20030223977A1
(en)
|
1991-03-01 |
2003-12-04 |
Ley Arthur Charles |
Kunitz domain mutants as cathepsin G inhibitors
|
|
WO1992018619A1
(en)
|
1991-04-10 |
1992-10-29 |
The Scripps Research Institute |
Heterodimeric receptor libraries using phagemids
|
|
US5166133A
(en)
*
|
1991-04-17 |
1992-11-24 |
Cetus Corporation |
Method for inhibing adhesion of white blood cells to endothelial cells
|
|
ES2206447T3
(es)
|
1991-06-14 |
2004-05-16 |
Genentech, Inc. |
Anticuerpo humanizado para heregulina.
|
|
DE4122599C2
(de)
|
1991-07-08 |
1993-11-11 |
Deutsches Krebsforsch |
Phagemid zum Screenen von Antikörpern
|
|
WO1993009233A2
(en)
|
1991-10-31 |
1993-05-13 |
The Salk Institute Biotechnology/Industrial Associates Inc. |
Recombinant amyloid precursor protein inhibitor domain and treatment of various disease states
|
|
IL104326A0
(en)
|
1992-01-07 |
1993-05-13 |
Novo Nordisk As |
Variant of human kunitz-type protease inhibitor
|
|
IL104325A
(en)
|
1992-01-07 |
2000-10-31 |
Novo Nordisk As |
Variants of human kunitz-type protease inhibitor domain II of tissue factor pathway inhibitor (TFPI) pharmaceutical compositions containing them a DNA construct encoding them their expression vectors a cell containing said DNA constructs and methods for the production of all the above
|
|
IL104314A0
(en)
*
|
1992-01-07 |
1993-05-13 |
Novo Nordisk As |
Human kunitz-type protease inhibitor and variants thereof,their production and pharmaceutical compositions containing them
|
|
IL104327A0
(en)
*
|
1992-01-07 |
1993-05-13 |
Novo Nordisk As |
Variant of human kunitz-type protease inhibitor
|
|
IL104324A0
(en)
|
1992-01-07 |
1993-05-13 |
Novo Nordisk As |
Variant of human kunitz-type protease inhibitor
|
|
CA2087413A1
(en)
|
1992-01-17 |
1993-07-18 |
Joseph R. Lakowicz |
Fluorescent energy transfer immunoassay
|
|
US5212091A
(en)
*
|
1992-03-02 |
1993-05-18 |
Monsanto Company |
Method of producing tissue factor pathway inhibitor
|
|
US6063764A
(en)
*
|
1992-06-01 |
2000-05-16 |
Washington University & Chiron Corp. |
Method for using lipoprotein associated coagulation inhibitor to treat sepsis
|
|
SE9201984D0
(sv)
|
1992-06-29 |
1992-06-29 |
Pharmacia Biosensor Ab |
Improvement in optical assays
|
|
JPH07509229A
(ja)
*
|
1992-07-13 |
1995-10-12 |
コルバス・インターナショナル、インコーポレイテッド |
ウシ膵トリプシン阻害因子から誘導される因子Ｘａの阻害因子
|
|
IL107831A0
(en)
*
|
1992-12-02 |
1994-05-30 |
Zymogenetics Inc |
Novel human amyloid protein precursor homolog and kunitz-type inhibitor
|
|
US5436153A
(en)
*
|
1992-12-02 |
1995-07-25 |
Sprecher; Cindy A. |
Human amyloid protein precursor homolog and Kunitz-type inhibitor
|
|
US5426224A
(en)
*
|
1993-03-18 |
1995-06-20 |
The University Of North Carolina At Chapel Hill |
Mammalian DNA topoisomerase II inhibitor and method
|
|
CA2170030A1
(en)
|
1993-09-14 |
1995-03-23 |
Robert A. Lazarus |
Pharmaceutical compositions containing ecotin and homologs thereof
|
|
US5455338A
(en)
|
1993-11-05 |
1995-10-03 |
Zymogenetics, Inc. |
DNA encoding novel human kunitz-type inhibitors and methods relating thereto
|
|
US5951974A
(en)
*
|
1993-11-10 |
1999-09-14 |
Enzon, Inc. |
Interferon polymer conjugates
|
|
US5446090A
(en)
*
|
1993-11-12 |
1995-08-29 |
Shearwater Polymers, Inc. |
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
|
|
US5759548A
(en)
*
|
1993-11-30 |
1998-06-02 |
Lxr Biotechnology Inc. |
Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
|
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
|
JP3805785B2
(ja)
|
1994-01-11 |
2006-08-09 |
ダイアックス コープ． |
カリクレイン阻害クニッツドメイン蛋白質およびその相同体
|
|
US6010880A
(en)
|
1994-01-11 |
2000-01-04 |
Dyax Corp. |
Inhibitors of human plasmin derived from the kunitz domains
|
|
US6057287A
(en)
*
|
1994-01-11 |
2000-05-02 |
Dyax Corp. |
Kallikrein-binding "Kunitz domain" proteins and analogues thereof
|
|
US5795954A
(en)
*
|
1994-03-04 |
1998-08-18 |
Genentech, Inc. |
Factor VIIa inhibitors from Kunitz domain proteins
|
|
ES2137509T3
(es)
*
|
1994-06-02 |
1999-12-16 |
Merrell Pharma Inc |
Perfluoroalquilcetonas, inhibidoras de elastasa y procedimientos para su preparacion.
|
|
US5589359A
(en)
*
|
1994-08-05 |
1996-12-31 |
Chiron Corporation |
Chimeric proteins
|
|
WO1996004377A1
(en)
*
|
1994-08-05 |
1996-02-15 |
Chiron Corporation |
Production of tissue factor pathway inhibitor
|
|
US5648331A
(en)
*
|
1994-08-26 |
1997-07-15 |
G.D. Searle & Co. |
Method of inhibiting tissue ischemia and reperfusion injury
|
|
DK0788546T3
(da)
*
|
1994-10-18 |
2007-04-10 |
Dendreon Corp |
Nematode-ekstraherede serinproteaseinhibitorer og antikoagulerende proteiner
|
|
US6159938A
(en)
|
1994-11-21 |
2000-12-12 |
Cortech, Inc. |
Serine protease inhibitors comprising α-keto heterocycles
|
|
MX9703988A
(es)
*
|
1994-12-12 |
1998-02-28 |
Omeros Med Sys Inc |
SOLUCIaN Y MÉTODO DE IRRIGACIaN PARA LA INHIBICIaN DEL DOLOR, LA INFLAMACIaN Y ES ESPASMO.
|
|
US5914316A
(en)
*
|
1994-12-16 |
1999-06-22 |
Washington University |
Method of inhibiting intimal hyperplasia
|
|
US5932462A
(en)
*
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
|
DK0813525T3
(da)
|
1995-03-10 |
2004-02-16 |
Berlex Lab |
Benzamidinderivater, deres fremstilling og anvendelse som antikoagulanter
|
|
US5695760A
(en)
*
|
1995-04-24 |
1997-12-09 |
Boehringer Inglehiem Pharmaceuticals, Inc. |
Modified anti-ICAM-1 antibodies and their use in the treatment of inflammation
|
|
AU2466895A
(en)
|
1995-04-28 |
1996-11-18 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5804376A
(en)
*
|
1995-05-02 |
1998-09-08 |
Incyte Pharmaceuticals, Inc. |
Pancreas-derived serpin
|
|
ZA963619B
(en)
*
|
1995-05-08 |
1996-11-22 |
Scios Inc |
Protease inhibitor peptides
|
|
AU5854096A
(en)
|
1995-05-08 |
1996-11-29 |
Scios Inc. |
Kunitz type protease inhibitors
|
|
US5786328A
(en)
*
|
1995-06-05 |
1998-07-28 |
Genentech, Inc. |
Use of kunitz type plasma kallikrein inhibitors
|
|
US5780265A
(en)
*
|
1995-06-05 |
1998-07-14 |
Genentech, Inc. |
Kunitz type plasma kallikrein inhibitors
|
|
US6242414B1
(en)
|
1995-06-07 |
2001-06-05 |
Chiron Corporation |
Regulation of cytokine synthesis and release
|
|
US6126933A
(en)
|
1995-06-27 |
2000-10-03 |
Genetics Institute |
Methods of treating inflammatory bowel diseases by administering IL-11
|
|
US5672662A
(en)
*
|
1995-07-07 |
1997-09-30 |
Shearwater Polymers, Inc. |
Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
|
|
JPH0959838A
(ja)
|
1995-08-24 |
1997-03-04 |
Kuraray Co Ltd |
紡績糸
|
|
EP0850064A1
(en)
*
|
1995-09-14 |
1998-07-01 |
Lxr Biotechnology Inc. |
Compositions with anti-apoptotic activity, containing a mixture of phospholipids
|
|
JP2000500120A
(ja)
*
|
1995-09-21 |
2000-01-11 |
ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション |
ポリ（エチレングリコール）と抗グルタミン酸デカルボキシラーゼ抗体の結合体の膵島細胞指向ターゲット化
|
|
US5736364A
(en)
*
|
1995-12-04 |
1998-04-07 |
Genentech, Inc. |
Factor viia inhibitors
|
|
BR9509985A
(pt)
|
1995-12-12 |
1998-11-03 |
Omeros Med Sys Inc |
Solução para irrigação e método para inibição de dor inflamação e esparmo
|
|
HU226419B1
(en)
|
1996-03-11 |
2008-12-29 |
Aerovance |
Human bikunin
|
|
US6013763A
(en)
*
|
1996-06-04 |
2000-01-11 |
Genentech, Inc. |
Peptide variants of protein A
|
|
US5869637A
(en)
*
|
1996-07-22 |
1999-02-09 |
Incyte Pharmaceuticals, Inc. |
Human Kallikrein
|
|
DE19632772A1
(de)
|
1996-08-14 |
1998-02-19 |
Basf Ag |
Neue Benzamidine
|
|
US6214966B1
(en)
|
1996-09-26 |
2001-04-10 |
Shearwater Corporation |
Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
|
|
US6255455B1
(en)
|
1996-10-11 |
2001-07-03 |
The Trustees Of The University Of Pennsylvania |
Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
|
|
US6258351B1
(en)
|
1996-11-06 |
2001-07-10 |
Shearwater Corporation |
Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels
|
|
JP4215172B2
(ja)
|
1996-12-03 |
2009-01-28 |
アムジェン フレモント インク． |
複数のＶ▲下Ｈ▼およびＶ▲下κ▼領域を含むヒトＩｇ遺伝子座を有するトランスジェニック哺乳動物、ならびにそれから産生される抗体
|
|
PT971946E
(pt)
|
1997-01-21 |
2006-11-30 |
Gen Hospital Corp |
Selecção de proteínas utilizando fusões arn-proteína
|
|
US5840871A
(en)
*
|
1997-01-29 |
1998-11-24 |
Incyte Pharmaceuticals, Inc. |
Prostate-associated kallikrein
|
|
AU6042298A
(en)
|
1997-01-31 |
1998-08-25 |
Human Genome Sciences, Inc. |
Tissue factor pathway inhibitor-3
|
|
US5962300A
(en)
|
1997-03-26 |
1999-10-05 |
Incyte Pharmaceuticals, Inc. |
Human kallikrein
|
|
US5990237A
(en)
*
|
1997-05-21 |
1999-11-23 |
Shearwater Polymers, Inc. |
Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
|
|
AU736549B2
(en)
|
1997-05-21 |
2001-08-02 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Method for the production of non-immunogenic proteins
|
|
US6362276B1
(en)
|
1998-01-07 |
2002-03-26 |
Debio Recherche Pharmaceutique S.A. |
Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom
|
|
US6362254B2
(en)
|
1998-03-12 |
2002-03-26 |
Shearwater Corporation |
Poly(ethylene glycol) derivatives with proximal reactive groups
|
|
US6455639B1
(en)
|
1998-03-24 |
2002-09-24 |
Nof Corporation |
Oxirane derivative and process for the preparation thereof
|
|
US6017723A
(en)
*
|
1998-03-27 |
2000-01-25 |
Long Island Jewish Medical Center |
Method for isolating inhibitors of protease activity
|
|
WO1999051773A1
(en)
|
1998-04-03 |
1999-10-14 |
Phylos, Inc. |
Addressable protein arrays
|
|
US6001596A
(en)
*
|
1998-05-07 |
1999-12-14 |
Incyte Pharmaceuticals, Inc. |
Growth-associated protease inhibitor heavy chain precursor
|
|
US6087473A
(en)
*
|
1999-05-26 |
2000-07-11 |
Zymogenetics, Inc. |
Kunitz domain polypeptide and materials and methods for making it
|
|
CA2330191A1
(en)
|
1998-06-03 |
1999-12-09 |
Scios, Inc. |
Protease inhibitor peptides
|
|
US6034053A
(en)
|
1998-07-13 |
2000-03-07 |
Wayne Hughes Institute |
EGF-isoflavone conjugates for the prevention of restenosis
|
|
DK2316475T3
(da)
|
1998-08-06 |
2017-11-20 |
Mountain View Pharmaceuticals Inc |
Isoleret tetramer urikase
|
|
US6783965B1
(en)
|
2000-02-10 |
2004-08-31 |
Mountain View Pharmaceuticals, Inc. |
Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
|
|
AU5805499A
(en)
|
1998-09-03 |
2000-03-27 |
Zymogenetics Inc. |
Kunitz domain polypeptide zkun6
|
|
US7067144B2
(en)
|
1998-10-20 |
2006-06-27 |
Omeros Corporation |
Compositions and methods for systemic inhibition of cartilage degradation
|
|
US6114382A
(en)
|
1998-11-11 |
2000-09-05 |
Moretti; Itagiba G. |
Methods for treating inflammatory bowel disease
|
|
CA2352538A1
(en)
|
1998-11-30 |
2000-06-08 |
Eli Lilly And Company |
Erythropoietic compounds
|
|
JP2002534959A
(ja)
|
1998-12-08 |
2002-10-22 |
バイオベーション リミテッド |
免疫原性タンパク質の改変方法
|
|
US6610503B1
(en)
|
1999-03-17 |
2003-08-26 |
Xenogen Corporation |
Animal models for predicting sepsis mortality
|
|
US20030012969A1
(en)
|
1999-04-06 |
2003-01-16 |
Clark Bert Thomas |
Soluble membrane strengthened paper products
|
|
US6605316B1
(en)
|
1999-07-31 |
2003-08-12 |
The Regents Of The University Of California |
Structures and fabrication techniques for solid state electrochemical devices
|
|
US6180607B1
(en)
|
1999-08-05 |
2001-01-30 |
Christopher Davies |
Protein having proteinase inhibitor activity
|
|
CA2381770C
(en)
*
|
1999-08-24 |
2007-08-07 |
Medarex, Inc. |
Human ctla-4 antibodies and their uses
|
|
KR20020065517A
(ko)
|
1999-11-12 |
2002-08-13 |
맥시겐 홀딩스 리미티드 |
인터페론 감마 접합체
|
|
GB9928787D0
(en)
|
1999-12-03 |
2000-02-02 |
Medical Res Council |
Direct screening method
|
|
US6348558B1
(en)
|
1999-12-10 |
2002-02-19 |
Shearwater Corporation |
Hydrolytically degradable polymers and hydrogels made therefrom
|
|
KR100729977B1
(ko)
|
1999-12-22 |
2007-06-20 |
넥타르 테라퓨틱스 에이엘, 코포레이션 |
폴리(에틸렌 글리콜)의 1-벤조트리아졸릴 카르보네이트에스테르의 제조 방법
|
|
US6544760B2
(en)
|
1999-12-22 |
2003-04-08 |
Zymogenetics, Inc. |
Kunitz domain polypeptide Zkun11
|
|
US6413507B1
(en)
|
1999-12-23 |
2002-07-02 |
Shearwater Corporation |
Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)
|
|
US20020102703A1
(en)
|
1999-12-29 |
2002-08-01 |
Sheppard Paul O. |
Kunitz domain polypeptide zkun10
|
|
GB9930882D0
(en)
|
1999-12-30 |
2000-02-23 |
Nps Allelix Corp |
GLP-2 formulations
|
|
EP1274731A1
(en)
|
2000-03-13 |
2003-01-15 |
Eli Lilly And Company |
Human hepatocyte growth factor activator inhibitor homologue
|
|
EP1803730A1
(en)
|
2000-04-12 |
2007-07-04 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
CN1331213A
(zh)
|
2000-06-30 |
2002-01-16 |
上海博德基因开发有限公司 |
一种新的多肽——人大蛋白10.01和编码这种多肽的多核苷酸
|
|
DE10034357C1
(de)
|
2000-07-14 |
2001-12-13 |
Elotherm Gmbh |
Verfahren und Vorrichtung zum Härten von Flächen an Bauteilen
|
|
CN100396329C
(zh)
|
2000-10-31 |
2008-06-25 |
德比奥药物股份有限公司 |
Epi-hne蛋白质悬浮液,其制备方法,其派生的干粉气溶胶,含有所述悬浮液或气溶胶的药物组合物及其应用
|
|
US20030113726A1
(en)
|
2000-12-04 |
2003-06-19 |
Zenta Tsuchihashi |
Human single nucleotide polymorphisms
|
|
TW593427B
(en)
|
2000-12-18 |
2004-06-21 |
Nektar Therapeutics Al Corp |
Synthesis of high molecular weight non-peptidic polymer derivatives
|
|
WO2002092147A2
(en)
|
2001-05-11 |
2002-11-21 |
Aradigm Corporation |
Optimization of the molecular properties and formulation of proteins delivered by inhalation
|
|
MY137181A
(en)
|
2001-05-21 |
2009-01-30 |
Nektar Therapeutics |
Pulmonary administration of chemically modified insulin
|
|
US20040152633A1
(en)
|
2001-05-31 |
2004-08-05 |
Jorgensen Marianne Ulrich |
Kunitz-type sequences and polypeptides
|
|
JP4287269B2
(ja)
|
2001-07-10 |
2009-07-01 |
日本電産サンキョー株式会社 |
バルブ駆動装置
|
|
US20030096733A1
(en)
|
2001-07-10 |
2003-05-22 |
Omnio Ab |
Novel drug targets for arthritis
|
|
US6913900B2
(en)
*
|
2001-08-29 |
2005-07-05 |
Nippon Zoki Pharmaceutical Co., Ltd. |
Plasma prekallikrein activation and kallikrein production assay
|
|
WO2003029456A1
(en)
|
2001-10-01 |
2003-04-10 |
Dyax Corp. |
Multi-chain eukaryotic display vectors and uses thereof
|
|
WO2003035842A2
(en)
|
2001-10-24 |
2003-05-01 |
Dyax Corporation |
Hybridization control of sequence variation
|
|
JP4653915B2
(ja)
|
2001-10-29 |
2011-03-16 |
独立行政法人科学技術振興機構 |
全身性エリテマトーデスモデル非ヒト動物
|
|
ES2392073T3
(es)
|
2001-11-08 |
2012-12-04 |
Abbott Biotherapeutics Corp. |
Formulación farmacéutica líquida estable de anticuerpos IGG
|
|
JP2005538932A
(ja)
|
2002-02-07 |
2005-12-22 |
アベンティス、ベーリング、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツング |
アルブミン融合クニッツドメインペプチド
|
|
EP2311432B1
(en)
|
2002-06-07 |
2014-12-24 |
Dyax Corporation |
Modified kunitz domain polypeptides and their use for reducing ischemia or the onset of a systemic inflammatory response associated with a surgical procedure
|
|
US7153829B2
(en)
|
2002-06-07 |
2006-12-26 |
Dyax Corp. |
Kallikrein-inhibitor therapies
|
|
US7132100B2
(en)
|
2002-06-14 |
2006-11-07 |
Medimmune, Inc. |
Stabilized liquid anti-RSV antibody formulations
|
|
MXPA05000797A
(es)
|
2002-07-24 |
2005-04-19 |
Hoffmann La Roche |
Polipeptidos t20 pegilados.
|
|
WO2004012773A1
(en)
|
2002-07-24 |
2004-02-12 |
F. Hoffmann-La Roche Ag |
Polyalkylene glycol acid additives
|
|
SI2386310T1
(sl)
|
2002-08-28 |
2019-03-29 |
Dyax Corp. |
Metode za ohranjanje organov in tkiv
|
|
US20040062748A1
(en)
|
2002-09-30 |
2004-04-01 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
|
US8129330B2
(en)
|
2002-09-30 |
2012-03-06 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
|
US7314613B2
(en)
|
2002-11-18 |
2008-01-01 |
Maxygen, Inc. |
Interferon-alpha polypeptides and conjugates
|
|
GEP20084486B
(en)
|
2002-12-26 |
2008-09-25 |
Mountain View Pharmaceuticals |
Polymer conjugates of interferon-beta with enhanced biological potency
|
|
ATE500345T1
(de)
|
2003-01-07 |
2011-03-15 |
Dyax Corp |
Kunitz-domäne-bibliothek
|
|
AU2004204720B2
(en)
|
2003-01-08 |
2009-08-06 |
Novartis Vaccines And Diagnostics, Inc. |
Stabilized aqueous compositions comprising tissue factor pathway inhibitor (TFPI) or tissue factor pathway inhibitor variant
|
|
CA2512680A1
(en)
|
2003-01-08 |
2004-07-29 |
Chiron Corporation |
Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants
|
|
US6989369B2
(en)
|
2003-02-07 |
2006-01-24 |
Dyax Corp. |
Kunitz domain peptides
|
|
GB0303085D0
(en)
|
2003-02-11 |
2003-03-19 |
Pfizer Ltd |
Model
|
|
CA2535859A1
(en)
|
2003-08-14 |
2005-03-03 |
Dyax Corp. |
Endotheliase-2 ligands
|
|
JP2007504169A
(ja)
|
2003-08-29 |
2007-03-01 |
ダイアックス コーポレーション |
修飾されたプロテアーゼインヒビター
|
|
ES2447423T3
(es)
|
2003-08-29 |
2014-03-12 |
Dyax Corp. |
Inhibidores de proteasa poli-pegilados
|
|
JP4653660B2
(ja)
*
|
2003-09-04 |
2011-03-16 |
独立行政法人理化学研究所 |
ＴＧＦ−β活性化制御領域の切断面を認識する抗体
|
|
US8114123B2
(en)
|
2003-09-19 |
2012-02-14 |
St. Jude Medical, Inc. |
Apparatus and methods for tissue gathering and securing
|
|
EP1689401A1
(en)
|
2003-10-02 |
2006-08-16 |
Elan Pharmaceuticals, Inc. |
Method for reducing pain
|
|
US20060228331A1
(en)
|
2003-10-10 |
2006-10-12 |
Novo Nordisk A/S |
IL-21 Derivatives and variants
|
|
WO2005041631A2
(en)
|
2003-10-21 |
2005-05-12 |
Dyax Corp. |
Endotheliase-1 ligands
|
|
US20070253949A1
(en)
|
2004-02-03 |
2007-11-01 |
Stefan Golz |
Diagnostics and Therapeutics for Diseases Associated with Plasma Kallikrein (KLKB1)
|
|
CA2575791A1
(en)
|
2004-08-03 |
2006-02-16 |
Dyax Corp. |
Hk1-binding proteins
|
|
US7235530B2
(en)
|
2004-09-27 |
2007-06-26 |
Dyax Corporation |
Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
|
|
CA2587775A1
(en)
|
2004-11-22 |
2006-06-01 |
Dyax Corp. |
Plasmin-inhibitory therapies
|
|
US8119137B2
(en)
|
2004-12-23 |
2012-02-21 |
Csl Behring Gmbh |
Prevention of thrombus formation and/or stabilization with inhibitors of factor XII or activated factor XII
|
|
WO2006089005A2
(en)
|
2005-02-17 |
2006-08-24 |
Bristol-Myers Squibb Company |
Combination of selective factor viia and/or xia and plasma kallikrein inhibitors
|
|
CA2607150C
(en)
|
2005-05-04 |
2014-08-05 |
Bjarne Due Larsen |
Glucagon-like-peptide-2 (glp-2) analogues
|
|
US20070079096A1
(en)
|
2005-09-30 |
2007-04-05 |
Chih-Wei Chen |
Data storage unit access authorization table automatic rebuilding method and system
|
|
DK1981519T3
(en)
|
2005-12-29 |
2018-02-19 |
Dyax Corp |
protease inhibition
|
|
US7276480B1
(en)
|
2005-12-30 |
2007-10-02 |
Dyax Corp. |
Prevention and reduction of blood loss
|
|
EP2001500A4
(en)
|
2006-03-10 |
2010-07-28 |
Dyax Corp |
FORMULATIONS FOR ECALLANTIDE
|
|
JP5337493B2
(ja)
|
2006-03-16 |
2013-11-06 |
ダイアックス コーポレーション |
セリンプロテアーゼを阻害するペプチドを用いて眼科障害を治療する組成物及び方法
|
|
EP1873344A1
(de)
|
2006-06-30 |
2008-01-02 |
Sika Technology AG |
Mittels Silikon agedichtete Verklebung
|
|
JP5322935B2
(ja)
|
2006-07-31 |
2013-10-23 |
アクティベサイト ファーマシューティカルズ インコーポレイティッド |
血漿カリクレインの阻害薬
|
|
WO2008060764A2
(en)
|
2006-10-05 |
2008-05-22 |
Drugtech Corporation |
Topical therapies for oral mucositis and other conditions
|
|
KR100846354B1
(ko)
|
2007-03-21 |
2008-07-15 |
(주) 프로탄바이오 |
혈청 당단백질부터 분리한 폐암 진단용 마커
|
|
WO2009026334A2
(en)
|
2007-08-21 |
2009-02-26 |
Genzyme Corporation |
Treatment with kallikrein inhibitors
|
|
AU2008288772A1
(en)
|
2007-08-23 |
2009-02-26 |
Genzyme Corporation |
Treatment with kallikrein inhibitors
|
|
US8359965B2
(en)
|
2007-09-17 |
2013-01-29 |
Oxford J Craig |
Apparatus and method for broad spectrum radiation attenuation
|
|
CA2715297A1
(en)
|
2008-02-13 |
2009-08-20 |
Dyax Corp. |
Improved methods for producing specific binding pairs
|
|
DE102008027574A1
(de)
|
2008-06-10 |
2009-12-17 |
Merck Patent Gmbh |
Neue Pyrrolidinderivate als MetAP-2 Inhibitoren
|
|
DE102008033095A1
(de)
|
2008-07-15 |
2010-01-28 |
Uhde Gmbh |
Vorrichtung zur Schlackeabführung aus einem Kohlevergasungsreaktor
|
|
MX2011000071A
(es)
|
2008-07-02 |
2011-05-03 |
Emergent Product Dev Seattle |
Inmunoterapeuticos de interleucina-6 (il6).
|
|
JP2013516389A
(ja)
*
|
2009-01-06 |
2013-05-13 |
ダイアックス コーポレーション |
カリクレイン阻害剤による粘膜炎治療
|
|
CN101928346B
(zh)
|
2009-07-31 |
2013-01-16 |
华中科技大学同济医学院附属同济医院 |
一种抗人组织激肽释放酶单克隆抗体及其制备
|
|
EP3459564B1
(en)
|
2010-01-06 |
2021-10-27 |
Takeda Pharmaceutical Company Limited |
Plasma kallikrein binding proteins
|
|
JP2014506257A
(ja)
|
2011-01-06 |
2014-03-13 |
ダイアックス コーポレーション |
血漿カリクレイン結合タンパク質
|
|
US8691861B2
(en)
|
2011-04-13 |
2014-04-08 |
Activesite Pharmaceuticals, Inc. |
Prodrugs of inhibitors of plasma kallikrein
|
|
TWI907924B
(zh)
|
2011-05-02 |
2025-12-11 |
日商武田藥品工業股份有限公司 |
抗-α4β7抗體之調配物
|
|
US10316095B2
(en)
|
2012-02-16 |
2019-06-11 |
Santarus, Inc. |
Antibody formulations
|
|
US9216219B2
(en)
|
2012-06-12 |
2015-12-22 |
Novartis Ag |
Anti-BAFFR antibody formulation
|
|
PT2946206T
(pt)
|
2013-01-20 |
2019-04-22 |
Dyax Corp |
Avaliação, ensaios e tratamento de distúrbios mediados por pkal
|
|
DK2948479T3
(en)
|
2013-01-20 |
2018-11-26 |
Dyax Corp |
EVALUATION AND TREATMENT OF BRADYKINE-MEDIATED DISORDERS
|
|
CN118406688A
(zh)
|
2013-03-15 |
2024-07-30 |
武田药品工业株式会社 |
抗血浆激肽释放酶抗体
|
|
KR20140119396A
(ko)
|
2013-03-29 |
2014-10-10 |
삼성전자주식회사 |
단백질 약물의 액상 제형
|
|
BR112016008970B1
(pt)
|
2013-10-21 |
2023-12-26 |
Takeda Pharmaceutical Company Limited |
Método de ativação ex vivo, método para avaliar ativação plasmática e ensaio ex vivo
|
|
KR20220107077A
(ko)
|
2014-01-21 |
2022-08-01 |
다케다 파머수티컬 컴패니 리미티드 |
혈장 칼리크레인 결합 단백질 및 유전성 혈관부종을 치료하는 데 있어서의 이의 용도
|
|
AU2015235967B2
(en)
|
2014-03-27 |
2020-10-22 |
Takeda Pharmaceutical Company Limited |
Compositions and methods for treatment of diabetic macular edema
|
|
BR112017020864A2
(en)
|
2015-03-30 |
2018-07-10 |
Dyax Corp. |
plasma kallikrein inhibitors and their uses for the prevention of hereditary angioedema attack
|
|
JP7003354B2
(ja)
|
2015-12-11 |
2022-03-04 |
武田薬品工業株式会社 |
遺伝性血管性浮腫の発作を治療するための血漿カリクレイン阻害薬およびその用途
|
|
KR102464380B1
(ko)
|
2016-09-16 |
2022-11-07 |
다케다 파머수티컬 컴패니 리미티드 |
접촉 활성화 시스템과 연관된 질환을 위한 대사물질 바이오마커
|
|
WO2019048960A1
(en)
|
2017-09-05 |
2019-03-14 |
Bat Call D. Adler Ltd. |
ELECTRONIC STHETHOSCOPE WITH IMPROVED FEATURES
|
|
EP3843840A1
(en)
|
2018-08-30 |
2021-07-07 |
Dyax Corp. |
Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
|
|
TW202100561A
(zh)
|
2019-03-14 |
2021-01-01 |
美商戴氏公司 |
血漿胰舒血管素抑制劑及其於治療遺傳性血管水腫發作的用途
|
|
JP2023510854A
(ja)
|
2020-01-13 |
2023-03-15 |
武田薬品工業株式会社 |
小児遺伝性血管性浮腫発作を治療するための血漿カリクレイン阻害剤及びその使用
|